查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2015140

神经科学用内视镜设备市场：2026-2032年全球市场预测（依产品类型、技术、应用、最终用户及销售管道）

Neurology Endoscopy Devices Market by Product Type, Technology, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，神经科学用内视镜设备市场价值将达到 2.7241 亿美元，到 2026 年将成长至 2.8498 亿美元，到 2032 年将达到 3.9213 亿美元，复合年增长率为 5.34%。

主要市场统计数据
基准年 2025 2.7241亿美元
预计年份：2026年 2.8498亿美元
预测年份 2032 3.9213亿美元
复合年增长率 (%) 5.34%

简要概述技术进步和临床需求如何改变整个医疗保健系统中神经外科内视镜的应用。

神经科学用内视镜器材市场正发展成为一个技术先进且临床敏感度极高的领域，精准医疗设备和微创医学的概念在此交会融合。影像技术、人体工学设计以及一次性抛弃式产品的进步，使得神经外科医师能够进行更多复杂的脑室内和颅底手术，同时降低术中併发症的风险。因此，医院和专科医疗中心正在调整其临床流程，将内视镜手术纳入治疗方案，即使是以往主要透过开颅手术治疗的疾病，也开始采用内视镜技术。

尖端诊断影像技术与一次性策略的整合正在重新定义设备设计、临床工作流程以及在临床环境中的应用。

神经科学用内视镜领域正经历一系列变革，从影像能力和一次性使用策略到临床中心的去中心化，无不体现这些变革。高清4K影像和3D视觉化技术透过为外科医生提供更清晰的解剖背景和深度讯息，改善了术中决策，从而减少了对辅助暴露和辅助手术的依赖。萤光导引能够更精确地显示肿瘤边界和识别血管，从而拓展了内视镜手术的临床适应症。

对新的进口关税调整如何影响整个医疗设备价值链的筹资策略、价格透明度和业务永续营运进行权威评估。

美国于2025年宣布的关税调整的累积影响，为神经科学用内视镜设备及其组件的供应链带来了新的复杂性。影响医疗设备组件、精密光学元件和某些电子子系统的关税调整，迫使製造商重新评估其采购地点、与主要供应商的合约条款以及成本分摊策略。随着进口关税推高投入成本，医疗设备製造商正在探索近岸外包和供应商多元化，以在不影响品质或合规性的前提下保护利润率。

从深刻的细分观点医疗设备类型、临床适应症、医疗机构、影像技术和销售管道与采用驱动因素和营运选择连结起来。

细分市场分析揭示了不同产品类型、应用、终端用户、技术和销售管道的细微效能趋势，这些趋势对于策略规划至关重要。产品类型包括软式内视镜、硬式内视镜和影像内视镜系统。硬式内视镜可细分为可重复使用型和一次性型，每种类型都存在独特的临床和操作方面的权衡。软式内视镜系统适用于解剖结构复杂的区域，而影像内视镜系统则作为先进成像模式的整合中心。

全面的区域分析将揭示报销方案、法规环境和基础设施成熟度的差异如何影响设备的部署和商业化路径。

区域趋势对神经科学用内视镜设备的普及、监管路径和经营模式有显着影响。在美洲，对先进诊断影像技术的投资以及高病患量三级医疗机构的集中，推动了整合式影像内视镜系统和先进视觉化辅助设备的快速普及。该地区的健保报销结构和医疗采购趋势也倾向于那些能够显着提高手术全期效率和病患管理能力的解决方案。

主要企业趋势与竞争行为：成熟参与者和专业创新者如何推动形象整合、培训计画和通路策略。

神经科学用内视镜设备生态系统的竞争格局呈现出两极化的特点：既有成熟的外科医疗设备製造商，也有灵活敏捷、专注于创新的创新企业。大型医疗技术公司利用其规模优势，将成像平台与医院IT系统整合，投资培训机构，并提供捆绑式服务合同，从而减轻医疗系统的管理负担。这些成熟企业通常强调丰富的产品系列、全面的保固服务以及支援多站点部署的全球服务网路。

为製造商和供应商制定可操作的策略重点，以协调技术投资、供应链韧性和临床培训与永续部署。

产业领导者应优先制定策略议程，使技术投资与临床疗效和供应链韧性保持一致。这首先应优先投资于能够增强术中决策的成像平台，特别是高清 4K 系统和3D可视化技术，同时在临床适用的情况下整合萤光引导，以提高手术精度。这些技术选择必须与以结果为导向的证据相结合，以证明其在安全性、效率和患者復原方面具有实际改进。

透过与医疗保健专业人员的访谈、技术整合和资料检验相结合的透明研究途径，可以对医疗设备的性能和采用因素得出可重复的见解。

本分析采用了调查方法结合结构化一手研究、严谨的二手资料整合和多面向资料检验的方法，以得出平衡且基于证据的结论。一手研究包括对执业神经外科医生、手术室主管、采购经理和服务技术人员进行详细访谈，以确定临床实践中设备性能、手术流程以及推广应用障碍等方面的考虑因素。与相关人员的这些对话提供了关于不同医疗机构的临床偏好、消毒实践和支持期望的定性见解。

一项权威的综合分析重点阐述了成像技术进步、一次性策略和供应链韧性如何决定采用趋势和临床结果。

总而言之，神经科学用内视镜设备生态系统正进入一个以成像技术快速创新、一次性使用策略的精细化以及新兴的供应链复杂性为特征的阶段。高解析度4K影像、 3D视觉化和萤光引导等技术进步正在扩大手术能力，并使微创治疗复杂颅内疾病成为可能。同时，可重复使用和一次性硬式内视镜的并存也为医疗系统硬式内视镜了操作上的选择，医疗系统必须权衡这些选择与消毒规范和资本投资规划之间的关係。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：神经科学用内视镜设备市场：依产品类型划分

  • 软式内视镜
  • 硬式内视镜
    • 可重复使用的
    • 一次性的
  • 影像内视镜系统

第九章：神经科学用内视镜设备市场：依技术划分

  • 萤光引导
  • 高清 4K 成像
  • 三维成像

第十章：神经科学用内视镜设备市场：依应用领域划分

  • 清除脑室内出血
  • 脑下垂体腺瘤切除术
  • 第三心室手术

第十一章神经科学用内视镜设备市场：依最终用户划分

  • 门诊手术中心
  • 医院
  • 专科诊所

第十二章：神经科学用内视镜设备市场：依销售管道划分

  • 直销
  • 销售代理
  • 线上销售平台

第十三章：神经科学用内视镜设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章神经科学用内视镜设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：神经科学用内视镜设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国神经科学用内视镜设备市场

第十七章：中国神经科学用内视镜设备市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Ackermann Instrumente GmbH
  • adeor medical AG
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Clarus Medical LLC
  • Fujifilm Holdings Corporation
  • HOYA Corporation
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • KARL STORZ SE & Co. KG
  • Medtronic plc
  • Olympus Corporation
  • Richard Wolf GmbH
  • Schindler Endoskopie Technologie GmbH
  • Stryker Corporation
Product Code: MRR-036C5CF3B4C5

The Neurology Endoscopy Devices Market was valued at USD 272.41 million in 2025 and is projected to grow to USD 284.98 million in 2026, with a CAGR of 5.34%, reaching USD 392.13 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 272.41 million
Estimated Year [2026] USD 284.98 million
Forecast Year [2032] USD 392.13 million
CAGR (%) 5.34%

A concise introduction to how technological advances and clinical imperatives are reshaping neurosurgical endoscopy adoption across health systems

The neurology endoscopy device landscape has evolved into a technically sophisticated, clinically nuanced arena where precision tools intersect with minimally invasive care paradigms. Advances in imaging, ergonomic design, and single-use disposables are increasingly enabling neurosurgeons to perform complex intraventricular and skull base procedures with reduced operative morbidity. As a result, hospitals and specialty centers are recalibrating care pathways to incorporate endoscopic approaches for conditions that were once predominantly managed through open craniotomy.

Clinical drivers are converging with operational imperatives: shorter inpatient stays, faster recovery trajectories, and improved visualization during delicate resections are enhancing the value proposition of endoscopic systems. Concurrently, technological progress in high-definition four k imaging, three dimensional visualization, and fluorescence guidance is expanding the clinical envelope, enabling procedures such as intraventricular hemorrhage evacuation and pituitary adenoma resection to be undertaken in settings with rigorous safety protocols. These dynamics are influencing procurement behaviors and capital planning, prompting health systems to reassess both device portfolios and training investments.

Beyond clinical and operational drivers, industry stakeholders are responding to changing reimbursement frameworks and regulatory scrutiny that prioritize device safety, traceability, and sterilization workflows. This intersection of clinical efficacy, economic accountability, and regulatory compliance is shaping the way manufacturers design products, structure warranties, and support clinical training programs. As a consequence, stakeholders across the value chain-from ambulatory surgery centers to large hospital networks-are seeking integrated solutions that combine instrument performance with service, training, and evidence generation.

How cutting edge imaging modalities and disposable strategies are converging to redefine device design, clinical workflows, and site of care adoption

The landscape of neurology endoscopy is being redefined by a set of transformative shifts that span imaging capability, disposability strategies, and care-site decentralization. High-definition four k imaging and three dimensional visualization have elevated intraoperative decision making by providing surgeons with clearer anatomical context and depth perception, which in turn reduces reliance on ancillary exposures and adjunctive procedures. Fluorescence guidance is enabling more precise tumor margin delineation and vascular identification, thereby expanding the clinical indications amenable to endoscopic approaches.

Parallel to imaging innovations, device designers are addressing infection control and workflow efficiency through the development of single use rigid endoscope variants alongside reusable platforms. This bifurcation in product strategy is altering hospital sterilization protocols and capital replacement cycles, while also creating new procurement considerations related to disposable cost per procedure versus long-term instrument maintenance. Moreover, the increased capability of video endoscope systems to integrate with hospital information systems and cloud-enabled analytics is accelerating the digitalization of the operating room, enabling performance benchmarking and remote proctoring.

Another pivotal shift is the movement of select neurosurgical procedures into ambulatory settings and specialized clinics, driven by shorter anesthesia times and faster recoveries. This shift necessitates a rethinking of service models, including support for training, device servicing, and inventory management. Collectively, these technological and care-delivery shifts are not isolated; they interact to reshape clinical pathways, procurement strategies, and competitive positioning across manufacturers and service providers.

An authoritative assessment of how new import duty adjustments are reshaping sourcing strategies, pricing transparency, and operational continuity across the device value chain

The cumulative impact of United States tariff changes announced in 2025 has introduced a new layer of complexity into supply chains for neurology endoscopy devices and their componentry. Tariff adjustments affecting medical device components, precision optics, and certain electronic subsystems have compelled manufacturers to reassess their sourcing footprints, contractual terms with tier one suppliers, and cost allocation strategies. As import duties shift input costs, device producers are evaluating nearshoring and supplier diversification to protect margins without compromising quality or compliance.

Manufacturers with globalized production models are particularly susceptible to tariff volatility, as changes in cross-border duties can amplify unit production costs and complicate pricing negotiations with health systems that operate under constrained capital budgets. In response, procurement teams at hospitals and specialty clinics are increasingly asking suppliers for clear total cost of ownership analyses that incorporate tariff-driven cost impacts, freight variability, and potential lead-time implications. This heightened scrutiny is prompting suppliers to be more transparent about their supply chain resilience measures, including inventory buffering, dual-sourcing arrangements, and alternative logistic pathways.

Furthermore, the tariff landscape has influenced strategic decisions regarding product configuration and packaging. Some manufacturers are redesigning kits to reduce the number of tariffable components crossing borders, while others are relocating final assembly to tariff-favored jurisdictions. These operational shifts are accompanied by implications for regulatory filings, quality assurance oversight, and service networks. For clinicians and administrators, the practical effect has been an increased emphasis on vendor stability and predictable supply commitments to avoid procedural disruptions and to maintain continuity of care.

Insightful segmentation perspectives that link device types, clinical indications, care settings, imaging technologies, and commercial channels to adoption drivers and operational choices

Segmentation analysis reveals nuanced performance dynamics across product type, application, end user, technology, and sales channel that are central to strategic planning. Within product type, the landscape encompasses flexible endoscopes, rigid endoscopes, and video endoscope systems; the rigid endoscope category further differentiates between reusable and single use variants, each presenting distinct clinical and operational tradeoffs. Flexible systems are being positioned for anatomically challenging corridors, while video endoscope systems serve as integrative hubs for advanced imaging modalities.

Application segmentation highlights clinical pathways such as intraventricular hemorrhage evacuation, pituitary adenoma resection, and third ventricle procedures, where device selection is guided by anatomical access, visualization requirements, and surgeon preference. Each indication has unique instrumentation demands and training curves, which in turn influence purchasing patterns and service needs. End user segmentation spans ambulatory surgery centers, hospitals, and specialty clinics, and the distribution of procedural volumes across these settings affects device configuration, purchasing contracts, and aftermarket service expectations.

Technology segmentation spotlights modalities including fluorescence guidance, high definition four k imaging, and three dimensional imaging. These technologies not only drive clinical capability but also determine systems integration requirements and capital expenditure profiles. Sales channel segmentation covers direct sales, distributor networks, and online sales platforms, each shaping the procurement experience, lead times, and support models. Taken together, these segmentation lenses provide a composite view of how product features, clinical indications, care settings, imaging technologies, and distribution routes jointly influence adoption dynamics and strategic priorities.

A comprehensive regional analysis describing how differentiated reimbursement, regulatory environments, and infrastructure maturity shape device adoption and commercialization pathways

Regional dynamics exert a powerful influence on adoption, regulatory pathways, and commercial models for neurology endoscopy devices. In the Americas, investment in advanced imaging and a concentration of high-volume tertiary centers support rapid adoption of integrated video endoscope systems and advanced visualization adjuncts. Reimbursement structures and institutional purchasing preferences in this region tend to favor solutions that demonstrate clear perioperative efficiency gains and improved patient throughput.

The Europe, Middle East & Africa region presents heterogeneity in regulatory harmonization, hospital procurement models, and infrastructure maturity. Western European centers often prioritize safety, sterilization workflows, and long-term service agreements, while some Middle Eastern and African healthcare systems are accelerating investments in tertiary neurosurgical capabilities, creating opportunities for modular systems that can adapt to diverse clinical settings. Cross-border regulatory considerations and regional distribution capabilities play a pivotal role in deployment strategies.

In the Asia-Pacific region, rapid expansion of specialty clinics and increasing procedural volumes are encouraging adoption of both reusable and single use rigid endoscopes, as well as portable video endoscope systems. Local manufacturing initiatives and regional supply chain evolution are contributing to competitive device pricing and faster time to market. Across regions, differences in training infrastructure, hospital accreditation standards, and clinical guideline adoption create distinct pathways for product entry and scale-up, shaping how manufacturers prioritize investments and tailor their commercial approaches.

Key corporate profiles and competitive behaviors revealing how incumbents and specialized innovators are advancing imaging integration, training programs, and channel strategies

Competitive dynamics within the neurology endoscopy device ecosystem are characterized by a mix of established surgical device manufacturers and agile specialized innovators. Large medical technology firms are leveraging scale to integrate imaging platforms with hospital IT systems, invest in training academies, and offer bundled service agreements that reduce administrative overhead for health systems. These incumbents typically emphasize broad product portfolios, comprehensive warranty structures, and global service footprints to support multi-site deployments.

Specialized firms and start-ups are differentiating through niche capabilities such as advanced fluorescence optics, compact four k imaging modules, and single use rigid endoscopes designed to streamline workflow and minimize cross-contamination risk. These players often pursue focused clinical evidence generation and close clinical partnerships to accelerate adoption in high-impact indications such as pituitary adenoma resections. Partnerships between imaging software providers and device manufacturers are becoming more common, enabling enhanced intraoperative guidance and post-procedure analytics.

Channel strategies also vary, with some companies favoring direct engagement to provide clinical education and procedural support, while others rely on distributor networks to expand geographic reach quickly. An increasing number of suppliers are experimenting with online platforms for consumables and accessory sales, improving replenishment cycles for ambulatory centers and specialty clinics. Across the competitive landscape, success is increasingly tied to the ability to demonstrate clinical outcomes, provide robust training, and maintain predictable service levels across geographies.

Actionable strategic priorities for manufacturers and providers to align technological investments, supply chain resilience, and clinical training with sustainable adoption

Industry leaders should prioritize a strategic agenda that aligns technology investment with clinical outcomes and supply chain resilience. First, prioritize investments in imaging platforms that enhance intraoperative decision making, particularly high definition four k systems and three dimensional visualization, while integrating fluorescence guidance where clinically appropriate to improve procedural precision. These technology choices should be paired with outcome-focused evidence generation that demonstrates tangible improvements in safety, efficiency, and patient recovery trajectories.

Second, develop flexible product portfolios that balance reusable instruments with single use rigid endoscopes to accommodate diverse hospital sterilization capabilities and infection control policies. This balanced approach mitigates supply disruptions and allows buyers to tailor device selection to procedural volume and capital constraints. Third, fortify supply chains through supplier diversification, nearshoring where feasible, and transparent cost structures that anticipate tariff and logistics volatility. Engaging early with procurement stakeholders to provide clear total cost perspectives will foster trust and reduce procurement friction.

Finally, invest in comprehensive clinical training and remote support capabilities to accelerate safe adoption across ambulatory surgery centers, hospitals, and specialty clinics. Training programs should include simulation, proctorship, and digital learning modules to shorten the learning curve. Combine these initiatives with flexible commercial models-such as outcome-based agreements and service bundles-that align incentives with healthcare providers and enhance long-term partnerships.

A transparent research approach combining clinician interviews, technical synthesis, and data triangulation to produce reproducible insights on device performance and adoption drivers

The research methodology for this analysis combined structured primary inquiry with rigorous secondary synthesis and multi-point data validation to ensure balanced, evidence-driven conclusions. Primary research consisted of in-depth interviews with practicing neurosurgeons, OR managers, procurement leads, and service technicians to surface real-world device performance considerations, procedural workflows, and adoption barriers. These stakeholder conversations provided qualitative insights into clinical preferences, sterilization practices, and support expectations across different care settings.

Secondary research encompassed peer-reviewed clinical literature, regulatory guidance documents, product technical specifications, and publicly available policy announcements to contextualize clinical efficacy, safety considerations, and regulatory trends. Data triangulation methods were employed to reconcile differences between anecdotal feedback and published evidence, ensuring that conclusions reflect convergent signals rather than isolated observations. Where appropriate, case studies were used to illustrate successful deploy-ment models and to highlight how technology choices translated into operational improvements.

Analytical steps included thematic coding of interview transcripts, comparative assessments of technology capabilities, and scenario analysis to evaluate the implications of tariff shifts and supply chain changes. Quality assurance protocols included cross-review by clinical and commercial subject matter experts to validate assertions and to minimize bias. The methodology emphasizes transparency and reproducibility, providing a robust foundation for the recommendations and insights presented herein.

A conclusive synthesis highlighting how imaging advances, disposable strategies, and supply chain resilience will determine adoption trajectories and clinical outcomes

In summary, the neurology endoscopy device ecosystem is entering a phase marked by accelerated imaging innovation, nuanced disposable strategies, and emergent supply chain complexity. Technology enhancements such as high definition four k imaging, three dimensional visualization, and fluorescence guidance are expanding surgical capabilities and enabling less invasive approaches for complex intracranial conditions. At the same time, the coexistence of reusable and single use rigid endoscopes introduces operational choices that health systems must reconcile with sterilization practices and capital planning.

External factors, including tariff adjustments and regional regulatory heterogeneity, are influencing sourcing decisions and commercial approaches. Manufacturers and providers that proactively address supply chain resilience, align product portfolios to clinical workflows, and invest in outcome-driven evidence and training will be best positioned to realize clinical and operational value. The path to wider adoption will be paved by collaborative partnerships that link device innovation with pragmatic service models, ensuring that technological advances translate into improved patient outcomes and sustainable care delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Neurology Endoscopy Devices Market, by Product Type

  • 8.1. Flexible Endoscope
  • 8.2. Rigid Endoscope
    • 8.2.1. Reusable
    • 8.2.2. Single Use
  • 8.3. Video Endoscope System

9. Neurology Endoscopy Devices Market, by Technology

  • 9.1. Fluorescence Guidance
  • 9.2. High Definition Four K Imaging
  • 9.3. Three D Imaging

10. Neurology Endoscopy Devices Market, by Application

  • 10.1. Intraventricular Hemorrhage Evacuation
  • 10.2. Pituitary Adenoma Resection
  • 10.3. Third Ventricle Procedure

11. Neurology Endoscopy Devices Market, by End User

  • 11.1. Ambulatory Surgery Center
  • 11.2. Hospital
  • 11.3. Specialty Clinic

12. Neurology Endoscopy Devices Market, by Sales Channel

  • 12.1. Direct Sales
  • 12.2. Distributor
  • 12.3. Online Sales Platform

13. Neurology Endoscopy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Neurology Endoscopy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Neurology Endoscopy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Neurology Endoscopy Devices Market

17. China Neurology Endoscopy Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Ackermann Instrumente GmbH
  • 18.6. adeor medical AG
  • 18.7. B. Braun Melsungen AG
  • 18.8. Boston Scientific Corporation
  • 18.9. Clarus Medical LLC
  • 18.10. Fujifilm Holdings Corporation
  • 18.11. HOYA Corporation
  • 18.12. Integra LifeSciences Holdings Corporation
  • 18.13. Johnson & Johnson Services, Inc.
  • 18.14. KARL STORZ SE & Co. KG
  • 18.15. Medtronic plc
  • 18.16. Olympus Corporation
  • 18.17. Richard Wolf GmbH
  • 18.18. Schindler Endoskopie Technologie GmbH
  • 18.19. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY VIDEO ENDOSCOPE SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY VIDEO ENDOSCOPE SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY VIDEO ENDOSCOPE SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY FLUORESCENCE GUIDANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY FLUORESCENCE GUIDANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY FLUORESCENCE GUIDANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY HIGH DEFINITION FOUR K IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY HIGH DEFINITION FOUR K IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY HIGH DEFINITION FOUR K IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY THREE D IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY THREE D IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY THREE D IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY INTRAVENTRICULAR HEMORRHAGE EVACUATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY INTRAVENTRICULAR HEMORRHAGE EVACUATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY INTRAVENTRICULAR HEMORRHAGE EVACUATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PITUITARY ADENOMA RESECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PITUITARY ADENOMA RESECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PITUITARY ADENOMA RESECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY THIRD VENTRICLE PROCEDURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY THIRD VENTRICLE PROCEDURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY THIRD VENTRICLE PROCEDURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY ONLINE SALES PLATFORM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY ONLINE SALES PLATFORM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY ONLINE SALES PLATFORM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. GCC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GCC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. GCC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 127. GCC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. GCC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. GCC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. GCC NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. G7 NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. G7 NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. G7 NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 148. G7 NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. G7 NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. G7 NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. G7 NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. NATO NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. NATO NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NATO NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 155. NATO NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. NATO NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. NATO NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. NATO NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. CHINA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY RIGID ENDOSCOPE, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA NEUROLOGY ENDOSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)